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Duchenne muscular dystrophy is the most commonly inherited neuromuscular disorder in
humans. Although the primary genetic deficiency of dystrophin in X-linked muscular dystrophy is
established, it isnotwell-knownhowpathophysiological events trigger the actual fibre degeneration.
We have therefore performed a DIGE analysis of normal diaphragm muscle versus the severely
affected x-linked muscular dystrophy (MDX) diaphragm, which represents an established animal
model of dystrophinopathy. Out of 2398 detectable 2-D protein spots, 35 proteins showed a drastic
differential expression pattern, with 21 proteins being decreased, including Fbxo11-protein, adeny-
late kinase, b-haemoglobin and dihydrolipoamide dehydrogenase, and 14 proteins being increased,
including cvHSP, aldehyde reductase, desmin, vimentin, chaperonin, cardiac and muscle myosin
heavy chain. This suggests that lack of sarcolemmal integrity triggers a generally perturbed protein
expression pattern in dystrophin-deficient fibres. However, the most significant finding was the
dramatic increase in the small heat shock protein cvHSP, which was confirmed by 2-D immuno-
blotting. Confocal fluorescence microscopy revealed elevated levels of cvHSP in MDX fibres. An
immunoblotting survey of other key heat shock proteins showed a differential expression pattern in
MDX diaphragm. Stress response appears to be an important cellular mechanism in dystrophic
muscle and may be exploitable as a new approach to counteract muscle degeneration.
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1 Introduction
Individual skeletal muscle proteins are relatively difficult to
isolate and analyse biochemically due to the rigid structure of
muscle fibres and the high density of contractile proteins and
intracellular membrane systems. Subcellular fractionation
procedures are often hampered by the cross-contamination
with highly abundant sarcoplasmic reticulum vesicles, and
high background levels of myosin, actin, troponin and tro-
pomyosin can make the purification of low-abundance mus-
cle proteins extremely difficult [1]. However, because of the
high frequency of genetic muscle disorders there is con-
siderable interest in studying protein expression and pro-
tein–protein interactions in normal versus diseased skeletal
muscles [2]. Proteomic screening of total cellular extracts [3]
embodies the ideal tool to overcome some of the technical
problems of basic myology [4]. Although 2-D gels of fibre
homogenates do not represent the entire muscle protein
complement, optimised electrophoretic procedures can
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separate a large and representative proportion of key meta-
bolic, structural, regulatory and contractile elements [5]. If
one accepts that certain high-molecular mass proteins, very
low-density components and proteins with extreme pI values
or certain PTMs may be under-represented in 2-D gels [6],
DIGE is one of the most powerful tools for conducting com-
parative biochemical investigations [7–9]. Unlu et al. [7] first
described this proteomics technology, and the first published
evaluation of its 2D software analysis was by Tonge et al. [8].
Advanced DIGE, using an internal pooled standard, is a
highly accurate quantitative method that enables multiple
protein samples to be separated on the same 2-D gel, thereby
greatly reducing the introduction of potential artefacts due to
gel-to-gel variations [9].
Comparative proteomics approaches are well suited for
studying the molecular pathogenesis of inherited muscular
disorders [10]. Often the identification of the primary genetic
abnormality and the elucidation of secondary changes may
not lead to a comprehensive understanding of the cellular
downstream events that render muscle fibres more suscep-
tible to necrosis [11]. In conjunction with findings from gene
expression profiling studies, proteomics can be used to study
how a specific mutation can perturb the global protein
expression pattern in a muscle. From the proteomics-based
categorisation of proteins with a drastically changed expres-
sion, conclusions about the compensatory up-regulation or
degeneration-dependent loss of specific cellular components
can be made. In the case of Duchenne muscular dystrophy,
the most commonly inherited neuromuscular disease in
humans [12], the primary deficiency in the membrane cyto-
skeletal protein dystrophin has been established for nearly
two decades [13]. The loss of dystrophin triggers the second-
ary loss of various surface proteins, such as dystroglycans,
sarcoglycans, syntrophins, dystrobrevin and sarcospan [14],
as well as associated signalling elements including the neu-
ronal isoform of nitric oxide synthase [15]. The molecular
collapse of the dystrophin–glycoprotein complex is believed
to weaken the linkage between the extracellular matrix and
the actin membrane cytoskeleton in muscle fibres [16].
However, it is not well understood how these primary and
secondary changes in fibre integrity finally lead to dis-
turbances of signal transduction, energy metabolism, ion
homeostasis and excitation–contraction coupling [11]. To
address this question, we have used DIGE analysis of the x-
linked muscular dystrophy (MDX) diaphragm to study
potential global disturbances in the protein expression pro-
file of dystrophin-deficient fibres. The MDX mouse dia-
phragm model of Duchenne muscular dystrophy exhibits
severe fibre degeneration [17] making it a suitable cellular
system to study the effects of dystrophin deficiency [18].
Large-scale transcriptomics and proteomics studies have
recently been performed to study normal skeletal muscle and
muscle disease processes. Skeletal muscle proteomics has
been successfully applied to evaluate differential expression
levels in fast versus slow fibres [19], chronic low-frequency-
stimulated fast muscle [20], the identification of age-de-
pendent protein nitration [21], the analysis of O-linked
N-acetylglucosamine proteins [22], the expression profiling
during muscle growth [23], and the general cataloguing of
muscle protein species [5, 6]. Besides comparative tran-
scriptomics screening of dystrophin-deficient muscle speci-
mens [24–28], MS-based proteomics led to the identification
of novel biomarkers in MDX tissues [29], such as adenylate
kinase [30], calsequestrin [31] and regucalcin [32]. These
investigations were performed with conventional non-
fluorescence gel electrophoresis techniques. In contrast,
here we have applied a several-fold more sensitive proteom-
ics method, DIGE [9], and have determined the expression
levels of fluorescently tagged normal versus dystrophic dia-
phragm proteins.
2 Materials and methods
2.1 Materials
CyDye DIGE fluor minimal dyes Cy2, Cy3 and Cy5, electro-
phoresis grade chemicals, IPG strips of pH 3–10 (linear) and
IPG buffer of pH 3–10 for IEF, the 2-D Quant kit for determi-
nation of protein concentration in electrophoretic samples, the
2-DClean-Up kit for removal of contaminants prior to IEF, and
ACN were obtained from Amersham Biosciences/GE Health-
care (Little Chalfont, Bucks., UK). DNase-I enzyme, ultrapure
lysine for quenching the DIGE labelling reaction, colloidal
CBB concentrate and the presilconisation medium Sigmacote
were from Sigma Chemical Company (Dorset, UK). For
desalting of MS samples, C-18 ZipTips were purchased from
Millipore Ireland B.V. (Carrigtwohill, Cork, Ireland). A matrix
kit containing CHCA was obtained from Laserbiolabs, Sophia-
Antipolis, France. For peptide generation, sequencing-grade
modified trypsin was purchased from Promega (Madison, WI,
USA). Ultrapure Protogel acrylamide stock solutions were
purchased from National Diagnostics (Atlanta, GA, USA). Pri-
mary antibodies were from Abcam, Cambridge, UK (pAb
ab21128 to cvHSP; pAb ab23855 to GRP75), StressGen Bio-
reagents, Victoria, Canada (pAb SPA-796 to HSP20; pAb SPA-
801 toHSP25;mAbLK-2 toHSP60;mAbBB70 toHSP70;mAb
16F1 to HSP90; pAb SPA-1103 to HSP110) and Vision-
biosystems Novocastra, Newcastle upon Tyne, UK (mAb 8D5
to b-dystroglycan). Peroxidase-conjugated secondary anti-
bodies were purchased from Chemicon International (Teme-
cula, CA, USA) and Alexa Fluor-conjugated secondary anti-
bodies were from Invitrogen Molecular Probes (Bio Sciences,
Dun Laoghaire, Ireland). The DNA-binding dye diamidino-
phenyindolewas fromSigma.Chemiluminescence substrates,
Immobilon NC-pure NC membranes and protease inhibitors
were obtained from Pierce and Warriner (Chester, UK), Milli-
pore (Bedford, MA, USA), and Roche Diagnostics (Mannheim,
Germany), respectively. Superfrost Plus positively charged
microscope slides were from Menzel Glässer (Braunschweig,
Germany). All other chemicals used were of analytical grade
and purchased from Sigma Chemical Company.
© 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
4612 P. Doran et al. Proteomics 2006, 6, 4610–4621
2.2 Dystrophic MDX animal model
The MDX mouse represents an established animal model of
X-linked muscular dystrophy [18]. In contrast to the relatively
mild phenotype of MDX limb muscle, the MDX diaphragm
exhibits severe fibre degeneration [17] and was therefore
chosen in this study. A primary deficiency in the Dp427 iso-
form of the membrane cytoskeletal protein dystrophin, due to
a point mutation in exon 23 [33], characterises this animal
model of Duchenne/Becker’s muscular dystrophy. Male mice
of the DmdMDX strain (Jackson Laboratory, Bar Harbor, Maine,
USA) of varying age and age-matched C57 controls were
obtained through the Animal House of the University of Bie-
lefeld and the Bioresource Unit of the National University of
Ireland, Maynooth. The Irish Higher Education Authority and
the Deutscher Akademischer Austauschdienst generously
supported laboratory visits to Germany by the Maynooth
team. For the initial optimisation of the electrophoretic
separation of crude diaphragm muscle samples and the sub-
sequent comparative DIGE procedure, an animal population
of 25 normal and 25 dystrophic mice was used. As previously
shown by 1-D immunoblot analysis, the MDX mouse cohort
used in this study lacks the 427 kDa isoform of dystrophin and
shows a drastic reduction in dystrophin-associated glycopro-
teins, such as dystroglycans and sarcoglycans [32]. According
to international standards of DIGE analysis [9], six control
samples, six MDX samples and six mixed standards were
prepared for the statistical analysis of the electrophoretically
separated muscle proteome using six DIGE gels. In addition,
samples for the preparation of two pick gels were prepared,
which were used in the mass spectrometric identification of
individual 2-D diaphragm protein spots.
2.3 Preparation and fluorescence labelling of muscle
protein extracts
Muscle specimens were quick-frozen in liquid nitrogen and
ground up into a fine powder using a pestle and mortar. For
comparative studies, equal amounts of normal and dystrophic
diaphragm tissue (,100 mg wet weight) were used. Muscle
powder was resuspended in 1 mL of lysis buffer containing
9.5 M urea, 4% w/v CHAPS, 0.5% ampholytes pH 3–10 and
100 mM DTT. In order to eliminate excessive viscocity due to
the presence of DNA, 2 mL of DNase-I (200 units) were added
per 100 mL of extraction buffer [31]. Extraction buffer was also
supplemented with a protease inhibitor cocktail (0.2 mM
pefabloc, 1.4 mM pepstatin, 0.15 mM aprotinin, 0.3 mM E-64,
1 mM leupetin, 0.5 mM soybean trypsin inhibitor, 1 mM
EDTA) to avoid proteolytic degradation of muscle proteins
[20]. The suspension was incubated for 3 h at room tempera-
ture, with gentle vortexing every 10 min for 30 s, and then
centrifuged at 47C for 20 min at 20 0006g. The protein-con-
taining middle layer was carefully removed and a portion of it
was saved for the determination of protein concentration
using the 2-D Quant kit from Amersham Biosciences/GE
Healthcare. Since excess lipids, salts and nucleic acids may
interfere with the proper 2-D separation of extracted proteins,
and because other interfering contaminants may compete for
the cyanine dyes, these substances were removed prior to IEF,
using the 2-D Clean-Up kit from Amersham Biosciences/GE
Healthcare. The precipitated protein fraction was resus-
pended in DIGE lysis buffer (9.5 M urea, 4% w/v CHAPS,
30 mM Tris-Cl, pH 8.5), mixed by gentle vortexing, pipetting
and ultrasonnication, and then adjusted to a protein con-
centration of 1 mg/mL [32]. The pH value of the suspension
was verified and, if needed, was adjusted using 30 mM Tris-
HCl. A 50 mg protein sample was labelled for each of the three
protein samples being studied, normal extracts were labelled
with Cy3 dye, MDX samples with Cy5 dye and the pooled
internal standard with Cy2 dye [9]. The labelling reaction was
carried out for 30 min on ice and in the dark, and then
quenched by incubation with 10 mM lysine for 10 min on ice.
The labelled protein extracts were pooled and immediately
used for electrophoresis. An equal volume of 26 sample buf-
fer (9.5 M urea, 4% CHAPS, 2% IPG Buffer pH 3–10 and
130 mM DTT) was added and this suspension was left on ice
for 10 min prior to electrophoretic separation.
2.4 2-DE
The 2-DE separation of fluorescently labelled muscle proteins
was carried out by standard procedure using the recom-
mended total protein concentration of 150 mg protein per
DIGE gel [7–9]. Using a reswelling tray from Amersham Bio-
sciences/GE Healthcare, IPG strips pH 3–10 (linear) were
rehydrated for 12 h with 0.45 mL of rehydration buffer
(9.5 M urea, 4% w/v CHAPS, 100 mM DTT, 1% ampholytes
pH 3–10), which had been complemented with 0.05% Bro-
mophenol blue as a tracking dye. Following placement of the
first-dimension strips gel-side up into the Ettan IPGphor
manifold and coverage with 108 mL of drystrip cover fluid,
protein samples were loaded by aniodic cup loading and were
then run on the IPGphor IEF system from Amersham Bio-
sciences/GE Healthcare. The following IEF gel running con-
ditions were used: 180 min at 300 V (step-and-hold), 180 min
at 600 V (gradient), 180 min at 1000 V (gradient), 180 min at
8000 V (gradient), 240 min at 8000 V (step-and-hold), 180 min
at 500 V (step-and-hold) and 120 min at 8000 V (step-and-
hold). After IEF, the strips were equilibrated for 15 min in
equilibration buffer (6 M urea, 30% w/v glycerol, 2% w/v
SDS, 100 mM Tris-HCl, pH 8.8) containing 100 mM DTTand
another 15 min in equilibration buffer supplemented with
0.25 M ideoacetamide. Using the Ettan Dalt-Twelve system
from Amersham Biosciences/GE Healthcare, the 2-D separa-
tion of muscle proteins was performed with 12.5% resolving
gels [32]. Following brief washing in SDS running buffer, IEF
strips were positioned on top of the second-dimension slab gel
with the help of a 1% w/v agrose sealing gel, poured on top of
the strip and left to solidify. The six DIGE gels and the two
pick gels were run for 0.2 W/gel for 1 h, followed by 0.4 W/gel
for 1 h, and then ran at 1.5 W per gel overnight until the blue
dye front had just disappeared from the bottom of the gel.
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2.5 Gel image acquisition and image analysis
Fluorescently labelled proteins were visualised using the
Typhoon Trio variable mode imager system from Amersham
Biosciences/GE Healthcare. Cy2, Cy3 and Cy5 images were
scanned using a 488, 532 and 633 nm laser, respectively [9].
The PMT value for all scanned images was between 500 and
560 V. All gels were scanned at 100 mm resolution and, prior
to analysis, gel images were cropped using the Image-
Quant TL software programme [9]. Gel analysis was per-
formed with the DeCyder V6.0 2-D analysis software package
for DIGE (Amersham Biosciences/GE Healthcare). The
DeCyder differential in-gel analysis (DIA) module was used
for pairwise comparision of each normal and dystrophic
MDX sample to the pooled standard present in each gel and
for the calculation of normalised spot volume/protein abun-
dance [9]. The 18-spor maps corresponding to the six gels
were used to calculate average abundance and paired Stu-
dent’s t-test p values for each protein across the six gels. This
was done using the DeCyder biological variation analysis
module (BVA) and Cy3:Cy2 and Cy5:Cy2 ratios for each in-
dividual protein. Protein spots that showed a 1.9-fold or more
increase or decrease were then identified using mass spec-
trometric fingerprinting analysis.
2.6 Mass spectrometric fingerprinting analysis
Colloidal Coomassie staining, washing of gels, in-gel diges-
tion and MALDI-TOF MS analysis were carried out as pre-
viously described in detail [20, 31]. Excised gel plugs of
interest were placed in 1.5 mL Eppendorf tubes that had
been presilconised with Sigmacote (Sigma Chemical Com-
pany) and then destained, desalted and washed by standard
procedure [31]. Gel pieces were rehydrated with digestion
buffer, containing 1 mg of trypsin (Promega) per 20 mL of
50 mM NH4HCO3, so that individual gel plugs were suffi-
ciently covered [32]. Following an incubation step for 60 min
at 377C, excess enzyme solution was removed and 3 mL of
50 mM NH4HCO3 was added to each gel plug in order to
keep gel pieces wet overnight. Samples were then cen-
trifuged at 12 0006g for 10 min and the resulting super-
natant was carefully removed from each incubation tube and
placed into a clean and silconised plastic tube. To aid diges-
tion, the gel plugs were treated by three sequential extraction
steps, as previously outlined [32], and then the extracted
solutions combined, concentrated and resuspended in 8 mL
of 3% v/v TFA and stored at 2707C until analysed by MS.
MALDI-TOF MS tryptic PMF of in-gel digests from normal
versus dystrophic MDX muscle protein species was carried
out by an optimised procedure [31, 32]. Following desalting
with Millipore C-18 ZipTips, tryptic peptides from individual
2-D muscle protein spots were eluted onto the sample plate
with the matrix solution, consiting of 5 mg/mL CHCA in
50% v/v ACN/0.1% v/v TFA. An Ettan MALDI-TOF Pro
instrument from Amersham Biosciences was used for the
recording of mass spectra, operating in the positive reflector
mode at the following parameters: accelerating voltage
20 kV; and pulsed extraction: on (focus mass 2500). For
internal calibration, standard peaks of angiotensin III
(897.5 m/z) and ACTH (2465.19 m/z), as well as trypsin
autolysis peaks at 842.50 and 2211.104 m/z, were used. For
the analysis of mass spectra, MALDI evaluation software was
employed and for the identification of protein species, the
PMF ProFound search engine for peptide mass fingerprints
was used. All certainty hits of diaphragm muscle proteins
generated by the ProFound search engine were matched
against the publicly available search engine MASCOT
(http://www.matrixscience.com).
2.7 Immunoblot analysis
2-DE separated muscle proteins were transferred at 100 V for
80 min to Immobilin NC-pure NC membranes using a
Transblot Cell from BioRad Laboratories (Hemel Hemp-
stead, Herts., UK) according to Towbin et al. [34] Ponceau-S-
Red staining of NC membranes was employed to evaluate
the efficiency of the electrophoretic transfer, followed by
destaining in PBS (50 mM sodium phosphate, 0.9% w/v
NaCl, pH 7.4). NC sheets were blocked for 1 h in 5% w/v fat-
free milk powder, dissolved in PBS. Incubation with suffi-
ciently diluted primary antibodies and peroxidase-con-
jugated secondary antibodies, as well as washing steps, were
performed as previously described in detail [35]. Immuno-
decorated 2-D protein spots were visualised using the Super-
Signal ECL kit from Pierce and Warriner. Densitometric
scanning of immunoblots was performed on a Molecular
Dynamics 300S computing densitometer (Sunnyvale, CA,
USA) with Imagequant V3.0 software.
2.8 Immunofluorescence microscopy
Cryosections of 10 mm thickness were prepared on a Thermo
Shandon Cryotome (Life Science International, Cheshire,
UK) and mounted on Superfrost Plus positively charged
microscope slides. For better handling and optimum sec-
tioning, individual diaphragms were carefully rolled into a
tube-like specimen, and then quick-frozen, fixed and blocked
as previously described [35]. Sections were cut at a slight
angle to expose both a transfer and longitudinal direction.
Cryoections were incubated overnight at 47C with primary
antibodies, carefully washed [35], and then incubated for
30 min at 257C with secondary antibodies that had been
conjugated to Alexa Fluor 488 dye or Alexa Fluor 594 dye.
Image acquisition was performed with an Olympus Fluo-
View FV1000 confocal laser scanning microscope (Olympus
Life and Material Science Europe, Hamburg, Germany)
using the Olympus FluoView Version 1.3c software package.
In order to establish the dystrophic status of MDX speci-
mens, normal and MDX cryosections were labelled with
antibodies to the dystrophin-associated glycoprotein b-dys-
troglycan, using Alexa Fluor 594 dye. The subcellular locali-
sation of the small heat shock protein cvHSP was carried out
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with Alexa Fluor dye 488. For labelling the position of nuclei
within muscle fibres, cryosections were incubated with the
DNA-binding dye diamidino-phenyindole [35].
3 Results
3.1 Sensitivity of DIGE technique for the detection of
diaphragm proteins
2-DE represents an extremely powerful biochemical technique
for the separation of proteins. Using standard 2-D gel ap-
proaches with conventional staining techniques, the total
number of detectable spots is usually in the range of several
100 proteins. In contrast, advanced DIGE, using the CyDye
DIGE fluor dyes Cy2, Cy3 and Cy5 for the labelling of pooled
standards, control samples and diseased samples, respectively,
can decisively increase the detection levels for comparative
proteomics studies [9]. Although skeletal muscle fibres are a
relatively difficult tissue to be properly separated by gel elec-
trophoresis, in this study the application of the DIGE tech-
nique resulted in the detection of 2398 individual 2-D muscle
protein spots. Previous studies on the 2-D separation of ske-
letal muscle proteins have reported 333 Hot Coomassie-
stained protein spots [32] and 652 Silver-stained protein spots
[5]. Consequently the DIGE analysis presented here shows an
approximately 3.7- to 7.2-fold increase in its protein detection
rate as compared to conventional staining techniques. Thus,
although certain diaphragm muscle species may still be
under-represented in the master gel shown in Fig. 1, and the
majority of the diaphragm proteins seen are probably mostly
soluble elements of muscle fibres or at least proteins that do
not exist in detergent-insoluble membrane complexes, the
DIGE approach exhibited a greatly enhanced detection rate.
3.2 Severely disturbed protein expression pattern in
dystrophin-deficient diaphragm
The comparative gel electrophoretic analysis of the normal
versus the MDX diaphragm proteome, using a Typhoon Trio
variable imager and DeCyder 2-D analysis software, revealed
that out of 2398 detectable 2-D protein spots, 35 proteins
showed a drastic differential expression pattern. Since no
specific diaphragm 2-D standard gel exists in the Swiss-2-D
PAGE mouse tissue databank, the spot pattern of our dia-
phragm gel (Fig. 1) was compared to the international mouse
limb muscle database (http://www.us.expasy.org/ch2d/). The
overall 2-D spot pattern of the master gel was found to be
comparable to published studies on the electrophoretic
separation of total skeletal muscle extracts [5, 6]. As illustrated
in Fig. 1, protein species with a changed abundance in MDX
diaphragm ranged in molecular mass from 6.2 kDa (a-globin)
to 223.7 kDa (myosin heavy chain) and covered a pI range
from pI 4.9 (vimentin) to pI 9.2 (isocitrate dehydrogenase).
An increased expression was found in the case of 14 muscle
proteins, and 21 diaphragm proteins were shown to be
Figure 1. 2-DE analysis of normal vs. MDX diaphragm muscle
extracts using DIGE analysis. Shown is a Cy2-labelled master gel
of total protein extracts from normal and dystrophic MDX dia-
phragm muscle. The pH values of the first dimension gel system
and molecular mass standards (in kDa) of the second dimension
are indicated on the top and on the left of the panels, respectively.
Proteins with a drastically different expression level are marked
by circles and are numbered 1–35. See Table 1 for a detailed list-
ing of diaphragm muscle proteins with a changed abundance in
dystrophin-deficient fibres.
decreased in their abundance. Table 1 lists the identification
of the majority of these proteins using MALDI-TOF MS
tryptic PMF from in-gel digests. Proteins with a disturbed
expression pattern belonged to the class of cellular compo-
nents that are involved in muscle contraction, cytoskeleton
formation, mitochondrial function, metabolism, ion home-
ostasis and chaperone function. Diaphragm proteins of
increased abundance in the MDX animal model could be
grouped as components involved in chaperone function
(cardiovascular heat shock protein/spot 1; chaperonin/
spot 11), aldehyde metabolism (aldehyde reductase/spot 2),
intermediate filament formation (desmin/spot 7; vimentin/
spot 10), muscle contraction (myosin heavy chains/spot 5
and 12), glycolysis (glyceraldehyde-3-phosphate dehy-
drogenase/spot 9), fatty acid oxidation (electron transferring
flavoprotein/spot 13) and nucleotide metabolism (Atp5b
protein/spot 14). The presence of the slow-twitch type I/car-
diac myosin heavy chain isoform (spot 5) clearly revealed the
special status of the diaphragm muscle within the various
skeletal muscle fibre groupings of contractile mouse tissues.
Diaphragm proteins of decreased abundance in the MDX
animal model could be grouped as components involved in
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Table 1. List of DIGE-identified muscle proteins that exhibit a drastic change of expression in dystrophin-deficient MDX diaphragm
Spot
no.
Name of identified proteins Sequence
coverage
(%)
Molecular
mass
(kDa)
pI Protein
accession
no.
Fold-
change
1/2
1 Heat shock protein cvHSP 21.3 18.66 5.8 gi[6636001] 18.09
2 Aldehyde reductase 18.2 36.80 6.9 gi[29374169] 13.82
3 Unknown protein – – – – 13.05
4 Unknown protein – – – – 12.82
5 Cardiac myosin heavy b-chain 10.5 223.66 5.6 gi[16508127] 12.43
6 Unknown protein – – – – 12.23
7 Desmin 24.9 53.54 5.2 gi[33563250] 12.14
8 Unknown protein – – – – 12.14
9 Glyceraldehyde-3-phosphate dehydrogenase-like protein 33.6 36.09 8.4 gi[51710824] 12.12
10 Vimentin 20.2 51.60 4.9 gi[2078001] 12.10
11 Chaperonin, HSP-1 23.4 61.11 5.7 gi[31981679] 12.00
12 Muscle myosin heavy chain 4.8 223.77 5.6 gi[71143152] 11.97
13 Electron transferring flavoprotein, a-polypeptide 34.2 35.27 8.8 gi[31981826] 11.96
14 Atp5b protein 27.0 56.28 5.2 gi[23272966] 11.93
15 Jmjd1a protein 10.3 67.61 6.6 gi[20071828] 21.91
16 Carbonic anhydrase 3 28.1 29.63 6.9 gi[13786200] 21.92
17 Isocitrate dehydrogenase 2 10.0 51.34 9.2 gi[37748684] 21.95
18 Unknown protein – – – – 21.95
19 Sorbitol dehydrogenase 28.0 40.64 6.6 gi[25108890] 21.97
20 Regucalcin 37.8 33.90 5.2 gi[6677739] 21.98
21 Alpha actin (aa27–375) 15.8 39.46 5.8 gi[49870] 22.13
22 Betaine-homocysteine methyltransferase 19.7 45.46 8.4 gi[62533211] 22.14
23 Aldh2 protein 18.1 57.03 7.7 gi[13529509] 22.15
24 Creatine kinase, mitochondrial 31.3 47.91 9.1 gi[38259206] 22.17
25 Aldolase 1, A-Isoform 25.5 39.75 8.9 gi[42490830] 22.31
26 Unknown protein – – – – 22.56
27 Alpha-globin 69.0 6.20 6.8 gi[193761] 22.65
28 Troponin I, fast muscle, TnI-2 37.4 21.51 8.8 gi[6678391] 22.65
29 Myosin light chain 29.4 22.52 5.0 gi[33563264] 22.77
30 Dihydrolipoamide dehydrogenase 20.4 54.76 8.3 gi[6014973] 22.79
31 Unknown protein – – – – 22.80
32 Unknown protein – – – – 23.08
33 Beta haemoglobin 54.1 15.76 7.3 gi[229301] 23.24
34 Adenylate kinase 1 31.9 23.33 5.7 gi[10946936] 23.24
35 F-box protein Fbxo11 10.4 58.58 6.6 gi[33243977] 23.52
protein ubiquination (Fbxo11 protein/spot 35), nucleotide
metabolism (adenylate kinase/spot 34; creatine kinase/
spot 24), oxygen transport (b-haemoglobin/spot 33; a-glo-
bin/spot 27), mitochondrial enzymes associated with the
formation of acetyl-coenzyme A (dihydrolipoamide dehy-
drogenase/spot 30), muscle contraction (myosin light chain/
spot 29; troponin/spot 28; actin/spot 21), glycolysis (aldo-
lase/spot 25), aldehyde metabolism (aldehyde dehy-
drogenase/spot 23), the remethylation pathway of homo-
cysteine homeostasis (betaine-homocysteine methyltransfer-
ase/spot 22), cytosolic calcium homeostasis (regucalcin/
spot 20), the polyol pathway of glucose metabolism (sorbitol
dehydrogenase/spot 19), the citric acid cycle (isocitrate
dehydrogenase/spot 17), the regulation of acid–base balance
(carbonic anhydrase/spot 16) and transcriptional control
(jumonji-domain containing Jmjd1a protein/spot 15).
3.3 Drastic increase of the heat shock protein cvHSP
in the dystrophic MDX diaphragm
The cardiovascular heat shock protein, cvHSP of 18.7 kDa
and pI 5.8, exhibited the highest fold change in expression of
the 35 detected diaphragm proteins. As shown in the en-
largements of Cy3-, Cy2- and Cy5-labelled gels (Fig. 2A–C),
two distinct protein spots positioned in close vicinity to the
myosin light chain isoforms represent the enzyme adenylate
kinase and cvHSP. In diaphragm, the apparent molecular
mass and pI value of myosin light chain isoforms MLC-3
(gi33563264) and MLC-2v (gi38511915) are 22.5 kDa/pI 5.0
and 18.8 kDa/pI 4.9, respectively. This correlates relatively
well with their position in the 2-D master gel (Fig. 1) and
appears to be different to gastrocnemius muscle where some
myosin light chains exhibit a slightly abnormal electropho-
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Figure 2. Differential expression pattern of the small heat shock protein cvHSP in normal vs. MDX diaphragm muscle. Shown is an
expanded view of 2-D gels of normal diaphragm (A), pooled standard (B) and dystrophic MDX diaphragm (C) from which the increased
expression levels of the cardiovascular heat shock protein (cvHSP; Protein Accession No. gi[6636001]) in MDX preparations can be
observed. In contrast, the myosin light chain isoform MLC-3, the cytosolic Ca21-binding protein regucalcin (RGN) and the enzyme adeny-
late kinase (AK1) are decreased in MDX diaphragm. Proteins in panels (A)–(C) were labelled with the CyDye DIGE fluor dyes Cy3, Cy2 and
Cy5, respectively. Major 2-D landmark proteins of unchanged abundance are represented by the two tropomyosin isoforms TPM-1a and
TPM-2b, troponin C (TnC), myosin light chain MLC-2v, a-actin, pyruvate dehydrogenase (PDH), aldehyde reductase (AR) and malate dehy-
drogenase (MDH). The portion of the 2-D gel (see Fig. 1) shown covers the range of approximately pH 3–6 in the first dimension and a
molecular mass range of approximately 10–40 kDa in the second dimension.
retic mobility pattern [6]. While the adenylate kinase spot is
drastically decreased in MDX gels, the cvHSP spot increased
dramatically in dystrophin-deficient preparations. It has
recently been reported that adenylate kinase and the Ca21-
binding protein regucalcin are both reduced in MDX skeletal
muscle using conventional proteomics [30, 32]. This agrees
with the findings represented in Fig. 2, whereby the reg-
ucalcin spot is positioned close to the tropomyosin TPM-1a
spot. Abundant landmark 2-D protein spots representing two
tropomyosin isoforms, actin, pyruvate dehydrogenase, alde-
hyde reductase and malate dehydrogenase showed a rela-
tively comparable expression level in normal versus MDX
diaphragm preparations. This confirms the reproducibility
of comparative approaches that employ DIGE analysis and
shows the significance of the drastic increase in the small
heat shock protein of 18.7 kDa.
3.4 Immunoblotting confirms increased cvHSP
expression in MDX diaphragm
Application of the DeCyder software programme for the
DIGE analysis of normal versus dystrophic MDX diaphragm
preparations revealed an approximate eight-fold increase in
protein spot 1 (Table 1). This finding is clearly illustrated in
the enlarged gel panel and its comparative graphic repre-
sentation of the cvHSP spot in Fig. 3A. To confirm this find-
ing, immunoblotting with a polyclonal antibody against a
synthetic peptide that corresponds to amino acids 150 to 166
of the human cvHSP protein, was performed. Since this
stretch of peptide sequence has 100% homology to mouse
cvHSP, antibody ab21128 to this small heat shock protein
represented the ideal tool to highly specifically detect the
immobilised mouse antigen. 2-D immunoblot analysis con-
firmed the drastic increase of cvHSP in the dystrophic MDX
diaphragm (Fig. 3B). The expression of the small heat shock
protein was shown to be approximately three-fold increased
in 9-wk-old MDX diaphragm and more than seven-fold
increased in 11-month-old dystrophic fibre preparations.
3.5 Immunofluorescence microscopy shows
increased cvHSP expression in MDX diaphragm
The biochemical findings from the immunoblotting of
cvHSP were confirmed by confocal laser scanning micro-
scopy, as illustrated in Fig. 4, using antigen labelling with
Alexa Fluor 488 dye-conjugated secondary antibodies to pri-
mary anti-cvHSP antibodies. As compared to normal skeletal
muscle, dystrophin-deficient MDX diaphragm fibres clearly
exhibited a drastically reduced expression level of the dystro-
phin-associated glycoprotein b-dystroglycan (Fig. 4A, D),
which has been shown previously [14, 16], and an increased
abundance of the heat shock protein cvHSP (Fig. 4C, F). The
position of nuclei within normal and dystrophic muscle
fibres was marked by the DNA-binding dye diamidino-phe-
nyindole (Fig. 4B, E). The combined images of Fig. 4G (nor-
mal) versus Fig. 4H (MDX), showing red fluorescence label-
ling for b-dystroglycan, green fluorescence labelling for
cvHSP and blue fluorescence labelling for nuclei, outline the
sarcolemmal localisation of the dystrophin-associated glyco-
protein and the mostly cytoplasmic localisation of the small
heat shock protein. The concentration of cvHSP was found
to be relatively low in normal fibres and appeared to be con-
centrated in subsarcolemmal regions. In stark contrast, all
fibres investigated in the MDX diaphragm exhibited a high
density of this heat shock protein throughout the cyto-
plasmic region, with a typical striated appearance in the
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Figure 3. Immunoblot analysis of the small heat shock protein
cvHSP in normal vs. MDX diaphragm muscle. Shown is a com-
parison of the results obtained with DIGE analysis (A) vs. immu-
noblotting (B) to determine the differential expression levels of
the small heat shock protein cvHSP in normal vs. dystrophic MDX
diaphragm. Panel (A) illustrates the eight-fold increase of the
cvHSP spot of 18.7 kDa and pI 5.8 in MDX preparations (see
Table 1). Shown is an expanded view of the Cy3- and Cy5-labelled
2-D gels of normal and dystrophic diaphragm, respectively, and
the comparative graphic representation of the cvHSP spot.
Immunoblotting with polyclonal antibody ab21128 against a
synthetic peptide that corresponds to amino acids 150–166 of the
human/mouse cvHSP protein documents an approximately
three-fold increase in 9-wk-old MDX diaphragm and a more than
seven-fold increase in 11-month-old dystrophic fibre prepara-
tions (n = 6; **p ,0.01; unpaired Student’s t-test).
longitudinal direction. This indicates a potential association
of cvHSP with contractile elements and/or cytoskeletal com-
ponents, and could therefore play a role in the stress re-
sponse to a damaged membrane cytoskeletal network in
dystrophin-deficient fibres.
3.6 Immunoblotting survey of key heat shock
proteins in MDX diaphragm
Based on the DIGE-generated finding that cvHSP is
increased in MDX diaphragm, it was of interest to survey the
fate of other key heat shock proteins in dystrophin-deficient
fibres. Figure 5A shows representative 2-D immunoblots of
Figure 4. Immunofluorescence localisation of cvHSP in normal
vs. MDX diaphragm. Shown is the confocal laser scanning
microscopical analysis of 11-month-old normal (A–C, G) vs. age-
matched MDX (D-F, H) diaphragm cryosections. The dystrophin-
associated glycoprotein b-dystroglycan (b-DG; A, D, G, H) and the
cardiovascular heat shock protein (cvHSP; C, F, G, H) were label-
led with antibody-conjugated Alexa Fluor 594 dye and Alexa
Fluor 488 dye, respectively. The position of nuclei within normal
and MDX muscle fibres was marked by the DNA-binding dye
diamidino-phenyindole (DAPI; B, E, G, H). The immuno-
fluorescence images indicate that sarcolemmal b-dystroglycan
levels are decreased in MDX diaphragm and that the cytosolic
abundance of cvHSP is drastically increased in dystrophin-defi-
cient fibres. Panels A–F show individual fluorescence images,
while panels G and H show combined fluorescence images. Bar
equals 40 mm.
the main subclasses of muscle heat shock proteins, and
Fig. 5B illustrates graphically the expression pattern of these
chaperones in normal versus dystrophic fibres. HSP25,
HSP60 and HSP70 appear not to be drastically changed in
their abundance in MDX diaphragm. No statistical analysis
is shown for HSP70 in Fig. 5B due to difficulties with high
background staining following antibody decoration, which
prevented reliable densitometric scanning. HSP20, GRP75
and HSP90 were shown to be reduced in dystrophin-defi-
cient fibres. In analogy to cvHSP, the large heat shock pro-
tein HSP110 was drastically increased in its expression in
MDX diaphragm preparations. Our immunoblotting survey
of the various representative heat shock proteins indicates a
differential expression pattern of key chaperones during
muscle degeneration in X-linked muscular dystrophy.
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Figure 5. Immunoblotting survey of key heat shock proteins in
the MDX diaphragm. Shown is the 2-D immunoblot analysis of
heat shock proteins HSP20, HSP25, HSP60, HSP70, GRP75,
HSP90 and HSP110, whereby lanes 1 and 2 represent 9-wk-old
normal and age-matched dystrophic preparations, respective-
ly (A). Panel (B) shows the comparative graphic representation of
immunodecoration with antibodies to the various subclasses of
muscle heat shock proteins (n = 6; **p ,0.01; unpaired Student’s
t-test). Due to problems with high levels of background staining,
no statistical evaluation of HSP70 is shown.
4 Discussion
Although prefractionation methods exist that can be employed
to remove abundant structural proteins prior to the 2-D
separation of muscle proteins [36], comparative proteomics
approaches usually try to avoid fractionation schemes in order
toachievea truerepresentationof the skeletalmuscleproteome
from normal versus diseased specimens [3]. By their very na-
ture, extraction procedures and centrifugation steps may
introduce artefacts.We therefore used total tissue preparations
in order to investigate the entire accessible proteome of control
versus MDX diaphragm. The list of 35 DIGE-identified dia-
phragm proteins that exhibited a drastic change of abundance
in MDX fibres indicates that a deficiency in the membrane
cytoskeletal protein dystrophin triggers a severely disturbed
protein expression pattern in muscular dystrophy. Although
the initial pathobiochemical consequence of a primary genetic
abnormality in the Dp427 isoform is clearly a drastic reduction
in dystrophin-associated glycoproteins and associated surface
components [11, 14, 16], this impairment of sarcolemmal
integrity appears to trigger a variety of downstream changes in
various cellular elements. The pathophysiological up- or down-
regulation in dystrophic fibres includes key diaphragm pro-
teins that are involved in chaperone function, ion homeostasis,
muscle contraction, cytoskeleton formation and metabolism.
Various metabolic marker components, such as proteins
associated with aldehyde metabolism, glycolysis, the citric
acid cycle, fatty acid oxidation, oxygen transportation,
nucleotide metabolism, the formation of acetyl-coenzyme
and the remethylation pathway are differentially affected in
the MDX diaphragm. In addition, important physiological
regulators that influence acid–base balance and cytosolic
calcium binding, are changed in dystrophin-deficient fibres.
The loss of a proper linkage between the actin membrane
cytoskeleton and the extracellular matrix in the dystrophic
plasmalemma seems to result in major disturbances in fibre
homeostasis and muscle metabolism, which encompasses
both the compensatory up-regulation of key enzymes and the
loss of other metabolic regulators. Microrupturing of the
dystrophic surface membrane has previously been impli-
cated in causing disturbed ion fluxes [37, 38]. Besides abnor-
mal ion cycling in dystrophic fibres, a reduction in overall
cellular integrity may also cause disturbed fluxes of meta-
bolic substrates and protein factors [39] and thereby nega-
tively influence the regulation of important pathways. Inter-
estingly, the decreased abundance in the Fbxo11 protein
involved in ubiquination agrees with studies that have shown
an impaired ubiquitin-proteasome system in muscle wasting
processes [40]. The approximate three-fold reduction of the
enzyme adenylate kinase in MDX diaphragm, as shown here
by DIGE analysis, has recently been shown in dystrophic
MDX hind limb fibres by conventional proteomics [30]. In
conjunction with creatine kinase, adenylate kinase provides a
major nucleotide pathway, and the lack of this key enzyme
indicates that an abnormal regulation of nucleotide ratios
occurs in dystrophic muscles. This appears to be a major
metabolic defect in dystrophinopathy.
Many potential biological and technical factors can com-
plicate the comparative proteomic analysis of total muscle
extracts, such as marked changes in the ratio of connective to
muscle fibres, alterations in the interstitial volume, residual
blood components or drastic shifts in fibre types. Hence,
changes in the abundance of contractile proteins, such as
actin and myosin isoforms, are difficult to judge. Degrada-
tion of the contractile apparatus should result in a compara-
ble loss and/or compensatory increase in the main con-
tractile components. However, such an analysis is compli-
cated by the presence of proteolytic fragments and the
potential aggregation of large muscle proteins during the
electrophoretic separation procedure. The DIGE analysis
presented here indicates a general disturbance of myosin
isoforms and actin, but it is not possible to make definitive
conclusions about fibre shifting in the dystrophin-deficient
diaphragm. Our recent proteomic analysis of the fast-to-slow
fibre transition process in chronic low-frequency stimulated
tibialis anterior muscle revealed distinct switches in troponin
and myosin isoforms [20]. Such drastic alterations in con-
tractile elements have not been observed in the MDX muscle
investigated here. Interestingly, it has previously been
reported that adult MDX muscle exhibits a wild-type pattern
of myosin heavy chain isoform expression [41]. This strongly
argues against a significant pathological fibre type shift in
the MDX animal model, and suggests that ongoing physical
activity, rather than the developmental history of a muscle, is
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the key determinant of myosin isoform expression. No
marked changes in the expression of albumin have been
shown by the DIGE analysis of the MDX diaphragm indicat-
ing that the relative volume and composition of the inter-
stitial space is probably comparable between normal and
dystrophin-deficient fibres. In contrast, the increased extra-
cellular space in conditioned muscle fibres was recognised
by a four-fold increase in albumin levels, as recently judged
by comparative proteomics [20]. This appears not to be the
case in the MDX diaphragm.
The increased sensitivity of the DIGE technique detected,
besides the previously identified changes in adenylate kinase
[30] and regucalcin [32], a drastic increase in the large heat
shock protein chaperonin and an important small heat shock
protein, cvHSP. Since the up-regulation of stress factors is an
essential response to cellular injury in many pathological
processes, this new result is a significant finding for our
understanding of muscular dystrophy. Besides heat shock,
diverse conditions such as inflammation, ischemia, oxidative
stress, exposure to heavy metals or certain amino acid ana-
logues, trigger the rapid synthesis of the highly conserved
group of heat shock proteins [42]. The multigene family of
HSP proteins functions mostly as chaperons [43]. They are
essential for normal cellular activity by associating with
malfolded proteins, thereby preventing their aggregating
into large deleterious complexes. HSP proteins enable cells
to survive stressful conditions by aiding the renaturation
process of malfolded proteins, but are also involved in influ-
encing the intracellular transport of mature proteins. In
addition to high-molecular mass heat shock proteins, a sub-
family of ten small heat shock proteins (smHSPs) exists in
mammalian species [44], including the cardiovascular heat
shock protein cvHSP [45]. Members of the smHSP class of
proteins range in molecular mass from 15 to 30 kDa. They
are characterised by a homologous domain of approximately
100 amino acids, the so-called a-crystallin domain [46].
Interestingly, the smHSP group of proteins mediates mostly
the stabilisation of cytoskeletal protein folding and transpor-
tation [46]. Thus, the up-regulation of cvHSP in a cytoskeletal
disease process, which is clearly present in dystrophino-
pathies, suggests that damaged muscle fibres attempt to
rescue their cellular integrity by modulating and repairing
the cytoskeletal network.
It has previously been reported in heart muscle that the
smHSP called aB-crystallin interacts with actin, desmin and
vimentin during biological stress [47]. A key function of
smHSPs appears to be the stabilisation of cytoskeletal struc-
tures, which is essential for cellular survival. This agrees
with our immunofluorescence analysis of cvHSP in MDX
diaphragm fibres, which indicates that this heat shock pro-
tein may be associated with cytoskeletal elements or the
contractile apparatus. In addition, the increased levels of
desmin and vimentin in the MDX diaphragm, as also iden-
tified in this DIGE-based study, could present a compensa-
tory mechanism of the dystrophic fibre. Vimentin and des-
min may strengthen the overall cellular integrity of the
muscle fibre by partially substituting for the loss of the
membrane cytoskeletal element dystrophin. Possibly, the
load-bearing function of the skeletal muscle cytoskeleton is
rescued by the up-regulation of the proteins that form the
structural backbone of intermediate filaments. Changes in
cvHSP have probably not been detected previously because
of the lack of sensitivity in detection levels of proteomics
approaches that employ conventional staining techniques,
such as Hot Coomassie or Silver staining. This clearly shows
the advantage of using DIGE-based approaches in compara-
tive proteomics [7–9].
Our finding that cvHSP, chaperonin and HSP-110
expression is increased in dystrophin-deficient fibres indi-
cates that the dystrophic fibre degeneration process appears
to trigger the up-regulation of specific chaperones that di-
rectly interact with and stabilise malfolded or damaged
muscle proteins. A previous immunohistochemical study
showed a changed expression pattern of large heat shock
proteins in dystrophin-deficient fibres [48]. HSP-65, HSP-72
and HSP-72/73 were shown to be significantly induced in
hypercontracted fibres [48]. Hypercontraction of fibres is a
specific histopathological feature of dystrophin-deficient
muscles [2] and is associated with a high frequency of cyto-
solic Ca21-loading [12, 49]. Increased cellular Ca21-levels
cause a pathological cycle of muscle protein degradation and
contractile weakness rendering fibres more susceptible to
necrosis [50]. In agreement with the cellular analysis of heat
shock protein expression in dystrophic muscles by Bornman
et al. [48], the proteomic profiling shown here suggests that
the induced stress response relate, at least partially, to the
metabolic abnormalities triggered by the deficiency in the
membrane cytoskeletal protein dystrophin. In addition, the
immunofluorescence localisation of cvHSP to the sub-
sarcolemmal cytosol in normal fibres and its drastically
increased density throughout the cytosplasm in MDX dia-
phragm, also indicates an important protective role of this
small heat shock protein in muscle fibre degeneration.
Previous studies have established that seven of the ten
identified small heat shock proteins are preferentially
expressed in striated muscle tissues and that they provide a
complex stress response system in skeletal muscle [44, 51].
An ischemia-induced stress response triggers the rapid
translocation of all small heat shock proteins to myofibrillar
targets in the Z/I-area of muscle fibres [44]. The 2-D immu-
noblot analysis presented here showed a differential re-
sponse of small heat shock proteins in muscular dystrophy.
HSP-20 expression was reduced, cvHSP expression
increased, and HSP25 expression relatively unchanged. To
fully understand these alterations in smHSP abundance, it is
essential to know their exact molecular-binding sites, which
has not yet been established [51]. Most likely a functional
hierarchy and possibly a certain degree of redundancy exist
within the smHSP family of chaperones. The differential
expression of cvHSP versus HSP20 and HSP25 during mus-
cle degeneration may reflect these variations in biological
function. The abundance of larger heat shock proteins, such
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as HSP60, which is associated with mitochondrial function,
and HSP70, which belongs to the main class of chaperones
that bind to peptides for re-/un-folding mechanisms, were
unchanged in the dystrophic diaphragm. This agrees with
the idea that, in contrast to nonmuscle tissues, the muscle-
specific small heat shock proteins may play a more impor-
tant role during fibre stress response than the HSP60 and
HSP70 family of proteins. The observed decrease in GRP75,
a glucose-regulated protein of the HSP70 family, and HSP90,
a binding component of protein kinases and the glucocorti-
coid receptor complex, may be associated with impaired cell
growth. This could negatively affect the repair mechanisms
of damaged fibres in dystrophin-deficient skeletal muscles.
On the other hand, the observed drastic increase in the very
large heat shock protein HSP110 could represent a muscle-
specific stress response and repair mechanism in muscular
dystrophy. The HSP100 family of chaperones is universally
conserved and appears to exhibit an interchangeable func-
tion with HSP70 proteins.
The up-regulation of chaperones probably represents an
autoprotective mechanism, whereby the stress response can
be considered a reaction to the pathological increase in
abnormally folded muscle proteins [51]. Interestingly, in
dystrophin-deficient muscles with a decreased pathology,
such as in MDX mice fed an iron-deficient diet, a reduction
in HSP70 expression was observed [52]. Thus, muscle
degeneration, metabolic stress and expression levels of heat
shock proteins appear to correlate in muscle diseases [48, 51].
Heat shock proteins seem to play a dual role in muscular
dystrophies. Firstly, they target denatured muscle proteins
and then assist in their proteolytic degradation or facilitate
the renaturation of malfolded peptide structures to initiate
cellular repair. Secondly, during regeneration newly synthe-
sised muscle proteins are chaperoned by various stress pro-
teins [51]. The induction of certain small heat shock proteins
may be beneficial in muscular dystrophy and the observed
increase of cvHSP in the dystrophic diaphragm strengthens
the concept that stress protein elements may play an impor-
tant role in dystrophinopathies.
The age groups of the dystrophic animal model studied
here, i.e. 9-wk- and 11-month-old MDX diaphragm fibres,
covers the established period of initial muscle degeneration
and the later onset fibre abnormalities in muscular dystro-
phy, respectively [18]. In contrast to the relatively mild
symptoms seen in MDX limb muscles, the MDX diaphragm
shows severe muscle wasting [17]. Following degeneration–
regeneration cycles, established early cellular changes that
are usually observed in MDX fibres of a few weeks of age are
segmental necrosis and central nucleation [18]. These histo-
logical abnormalities are associated pathobiochemically with
the loss of dystrophin-associated glycoproteins (sarcogly-
cans, dystroglycans, sarcospan, dystrobrevins, syntrophins),
Ca21-binding proteins (calsequestrin, sarcalumenin, reg-
ucalcin) and dystrophin-linked enzymes (neuronal isoform
of nitric oxide synthase) [16]. In contrast to young MDX
muscles, a drastic increase in collagen deposits is present in
several months old MDX fibres, which is a similarity to the
severely dystrophic fibres from patients afflicted with Duch-
enne muscular dystrophy [12]. The immunoblot analysis of
cvHSP, presented in this report, indicates that the increase
in expression of this small heat shock protein intensifies
with the age of the MDX mouse. There appears to be a cor-
relation between the severity of the muscle degeneration
process and the cellular stress response. With respect to
developing novel therapeutic strategies to counteract muscle
degeneration by targeting downstream events [53, 54], mod-
ulating the stress response might be a possibility. That this is
a realistic biomedical option has recently been shown in cell-
based therapy approaches. Heat shock treatment appears to
enhance the survival of transplanted myoblasts [55]. Since
up-regulation of heat shock proteins represents an autopro-
tective mechanism during biological stress, the pharmacolo-
gical or cell therapeutic enhancement of this natural re-
sponse may be useful for counteracting excessive muscle
wasting in X-linked muscular dystrophy.
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